2-216694726-G-C
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The ENST00000233813.5(IGFBP5):āc.50C>Gā(p.Pro17Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000199 in 1,306,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000233813.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IGFBP5 | NM_000599.4 | c.50C>G | p.Pro17Arg | missense_variant | 1/4 | ENST00000233813.5 | NP_000590.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IGFBP5 | ENST00000233813.5 | c.50C>G | p.Pro17Arg | missense_variant | 1/4 | 1 | NM_000599.4 | ENSP00000233813 | P1 | |
DIRC3-AS1 | ENST00000695932.1 | n.323G>C | non_coding_transcript_exon_variant | 1/12 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000110 AC: 1AN: 90574Hom.: 0 AF XY: 0.0000201 AC XY: 1AN XY: 49816
GnomAD4 exome AF: 0.0000199 AC: 26AN: 1306632Hom.: 0 Cov.: 30 AF XY: 0.0000251 AC XY: 16AN XY: 636808
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 31, 2024 | The c.50C>G (p.P17R) alteration is located in exon 1 (coding exon 1) of the IGFBP5 gene. This alteration results from a C to G substitution at nucleotide position 50, causing the proline (P) at amino acid position 17 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at